Prediction of Boron Concentrations in Blood from Patients on Boron Neutron Capture Therapy

Anticancer Research

Volumn 23, Issue 6 D, 2003, Pages 5231-5235

  Shibata, Yasushi ^a   Matsumura, Akira ^a   Yamamoto, Tetsuya ^a   Akutsu, Hiroyoshi ^a   Yasuda, Susumu ^a   Nakai, Kei ^a   Nose, Tadao ^a   Yamamoto, Kazuyoshi ^b   Kumada, Hiroaki ^b   Hori, Naohiko ^b   Ohtake, Shinichi ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JAPAN ATOMIC ENERGY AGENCY   (Japan)

Author keywords

Boron neutron capture therapy; BSH; Glioblastoma; Prompt gamma ray analysis; Radiation therapy

Indexed keywords

BORON; BORON DERIVATIVE; SODIUM UNDECAHYDRODODECABORATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BLOOD LEVEL; BRAIN TUMOR; CANCER RADIOTHERAPY; FEMALE; GAMMA IRRADIATION; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTRON CAPTURE THERAPY; PREDICTION; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ADULT; AGED; ASTROCYTOMA; BORON; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TISSUE DISTRIBUTION;

EID: 10744228240     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Report of Brain Tumor Registry of Japan (1969-1993). Neurol Med Chir (Tokyo) 40 Suppl: 1-106, 2000.
2. Davis FG, Freels S, Grutsch J, Barlas S and Brem S: Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 88: 1-10, 1998.
3. Barth RF, Soloway AH, Goodman JH, Gahbauer RA, Gupta N, Blue TE, Yang W and Tjarks W: Boron neutron capture therapy of brain tumors: an emerging therapeutic modality. Neurosurgery 44: 433-450, 1999.
4. Zamenhof RG, Busse PM, Harling OK and Goorley JT: Boron neutron capture therapy. In: The Modern Technology of Radiation Oncology (Dvk JV, eds). Madison, Wisconsin, Medical Physics Publishing, 1999, pp 981-1020.
5. Matsumura A, Yamamoto T, Shibata Y, Nakai K, Zhang T, Matsushita A, Takano S, Endo K, Akutsu H, Yamamoto K, Kumada H, Torii Y, Mizutani T, Takahashi H, Toyooka H and Nose T: Intraoperative boron neutron capture therapy using thermal/epithermal mixed beam. In: Research and Development in Neutron Capture Therapy (Sauerwein W, Moss R and Wittig A, eds). Bologna, Mondussi Editore, 2002, pp 1073-1078.
6. Chadha M, Capala J, Coderre JA, Elowitz EH, Iwai J, Joel DD, Liu HB, Wielopolski L and Chanana AD: Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory. Int J Radiat Oncol Biol Phys 40: 829-834, 1998.
7. Chanana AD, Capala J, Chadha M, Coderre JA, Diaz AZ, Elowitz EH, Iwai J, Joel DD, Liu HB, Ma R, Pendzick N, Peress NS, Shady MS, Slatkin DN, Tyson GW and Wielopolski L: Boron neutron capture therapy for glioblastoma multiforme: interim results from the phase I/II dose-escalation studies. Neurosurgery 44: 1182-1193, 1999.
8. Coderre JA, Elowitz EH, Chadha M, Bergland R, Capala J, Joel DD, Liu HB, Slatkin DN and Chanana AD: Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results. J Neurooncol 33: 141-152, 1997.
9. Hatanaka H and Nakagawa Y: Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int J Radiat Oncol Biol Phys 28: 1061-1066, 1994.
10. Nakagawa Y and Hatanaka H: Boron neutron capture therapy. Clinical brain tumor studies. J Neurooncol 33: 105-115, 1997.
11. Takagaki M, Oda Y, Miyatake S, Kikuchi H, Kobayashi T, Sakurai Y, Osawa M, Mori K and Ono K: Boron neutron capture therapy: preliminary study of BNCT with sodium borocaptate (Na2B1 2H1 1SH) on glioblastoma. J Neurooncol 35: 177-185, 1997.
12. Kiger WS, Palmer MR, Riley KJ, Zamenhof RG and Busse PM: A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans. Radiat Res 155: 611-618, 2001.
13. Horn V, Pharm D, Slansky J, Janku I, Strouf O, Sourek K and Tovarys F: Disposition and tissue distribution of boron after infusion of borocaptate sodium in patients with malignant brain tumors. Int J Radiat Oncol Biol Phys 41: 631-638, 1998.
14. Kageji T, Nagahiro S, Kitamura K, Nakagawa Y, Hatanaka H, Haritz D, Grochulla F, Haselsberger K and Gabel D: Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma. Int J Radiat Oncol Biol Phys 51: 120-130, 2001.
15. Ceberg CP, Persson A, Brun A, Huiskamp R, Fyhr AS, Persson BR and Salford LG: Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: a basis for boron neutron capture therapy. J Neurosurg 83: 79-85, 1995.
16. Gabel D, Preusse D, Haritz D, Grochulla F, Haselsberger K, Fankhauser H, Ceberg C, Peters HD and Klotz U: Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical trial of boron neutron capture. Acta Neurochir (Wien) 139: 606-611, 1997.
17. Haritz D, Gabel D and Huiskamp R: Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT). Int J Radiat Oncol Biol Phys 28: 1175-1181, 1994.
18. Haselsberger K, Radner H and Pendl G: Boron neutron capture therapy: boron biodistribution and pharmacokinetics of Na2B12H11SH in patients with glioblastoma. Cancer Res 54: 6318-6320, 1994.
19. Kageji T, Nakagawa Y, Kitamura K, Matsumoto K and Hatanaka H: Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors. J Neurooncol 33: 117-130, 1997.
20. Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, Gupta N, Gahbauer RA, Adams DM, Gibson CR, Ferketich AK, Moeschberger ML, Soloway AH, Carpenter DE, Albertson BJ, Bauer WF, Zhang MZ and Wang CC: Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas. Neurosurgery 47: 608-621, 2000.
21. Stragliotto G and Fankhauser H: Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors. Neurosurgery 36: 285-292, 1995.